ask="13.60"
ask_size="1000"
average_daily_volume="403358"
bid="9.05"
bid_size="100"
book_value="3.69"
change="-0.15"
change_from_200_day_moving_average="-0.82"
change_from_50_day_moving_average="1.75"
change_from_52_week_high="-4.85"
change_From_52_week_low="5.69"
change_in_percent="-1.52%"
close="9.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.51"
eps_estimate_next_year="-1.95"
ex_dividend_date="N/A"
float_shares="16088000"
high="10.00"
high_52_weeks="14.60"
last_trade_date="3/14/2017"
last_trade_price="9.75"
last_trade_size="2996"
last_trade_time="4:00pm"
low="9.05"
low_52_weeks="4.06"
market_capitalization="174.00M"
moving_average_200_day="10.57"
moving_average_50_day="8.00"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="9.80"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-7.73%"
percent_change_from_50_day_moving_average="+21.90%"
percent_change_from_52_week_high="-33.22%"
percent_change_from_52_week_low="+140.21%"
previous_close="9.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.69"
price_per_sales="186.44"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.42"
stock_exchange="NCM"
symbol="STML"
volume="297493"
weeks_range_52="4.06 - 14.60"
